Coronary Stents Pipeline Analysis: Key MedTech Companies are set to develop new devices and explore countless opportunities

July 02 01:02 2021
Coronary Stents Pipeline Analysis: Key MedTech Companies are set to develop new devices and explore countless opportunities

Coronary Stents Pipeline
DelveInsight’s Coronary Stents pipeline report gives detailed insights into the Coronary Stents pipeline landscape, including 20+ companies and 20+ pipeline devices. This report also examines the emerging Coronary Stents devices in depth, as well as the competitive landscape, in order to better understand the market.

DelveInsight’s Coronary Stents pipeline report gives detailed insights into the Coronary Stents pipeline landscape, including 20+ companies and 20+ pipeline devices. This report also examines the emerging Coronary Stents devices in depth, as well as the competitive landscape, in order to better understand the market.

Some of the Key Highlights from the Coronary Stents Pipeline Report

  • Boston Scientific Corporation’s product, SYNERGYTM Everolimus-Eluting Platinum Chromium Coronary Stent System, a coronary stent system designed to treat patients with a constricted blood vessel (coronary artery) due to coronary artery disease, was approved by the Food and Drug Administration (FDA) on August 11, 2020. 

  • MedAlliance was awarded the fourth FDA Breakthrough Device Designation for its Sirolimus Drug-Eluting Balloon in the treatment of De Novo Coronary Lesions on March 3, 2021.

  • Xience Sierra Stent and Xience Alpine Everolimus Eluting Coronary Stent System by Abbott are the approved devices available in the Coronary Stents Market.

  • Firesorb (MicroPort CRM), Virtue Sirolimus AngioInfusion Balloon (Orchestra BioMed), and others are among the pipeline devices which may soon join the Coronary Stents market.

  • Abbott, Terumo Corporation, Cook Medical, B. Braun Medical, Orchestra Biomed, Bioheart, MicroPort, ATEM and others are among the key MedTech companies which are active in the Coronary Stents market. 

To know more, request sample @ Coronary Stents Market 

Coronary Stent: Overview

Coronary stents are expandable tubular metallic devices that can be used to clear congested arteries in patients with underlying atherosclerosis. After the stent is inserted, the revascularization process is also known as percutaneous coronary intervention or coronary angioplasty.

Different types of Coronary Stents

Bare-Metal Stents

Bare metal stents are made of tiny mesh wired tubes that allow the clogged artery to be widened but do not include a polymer or drugs coating to help prevent re-blockage of the arteries. Patients who are allergic to specific polymers or who do not require drugs eluted from drug eluting stents can benefit from these stents.

Drug-Eluting Stents

When the arteries are about to re-block, a drug-eluting stent is a bare-metal stent with a polymer covering that allows for the progressive release of drugs over a period of time. Drug-eluting stents help to reduce the odds of a repeat arterial blockage. These further are of two types: Permanent Polymer Drug-Eluting Stent and Bioresorbable Polymer Drug-Eluting Stent.

Have queries? Where are stents placed? Find out your answer @ Coronary Stents Placement

Coronary Stents Key Companies

  • Abbott

  • Terumo Corporation

  • Cook Medical

  • B. Braun Medical

  • Orchestra Biomed

  • Bioheart

  • MicroPort

  • ATEM

Coronary Stents Assessment

  • By Product Type

    • Drug Eluting Stents

    • Bare Metal Stents

    • Bioabsorbable Scaffolds

  • By Stage Type 

    • Pre-clinical

    • Clinical

Coronary Stents Market Drivers

  • Rising prevalence of cardiovascular diseases such as stroke and heart attack

  • Increasing technological advancement 

  • Increasing levels of geriatric population that are at a risk of cardiac health

Coronary Stents Market Barriers

  • Product Recalls

  • Product-related safety concerns

  • Stringent government approvals

Coronary Stents Unmet Needs 

  • Need for more emphasis on product safety

  • Less health expenditure in low- and middle-income countries

Scope of the Report

Coverage: Global

Coronary Stents Key Companies: Abbott, Terumo Corporation, Cook Medical, B. Braun Medical, Orchestra Biomed, Bioheart, MicroPort, ATEM, among others

PEST Analysis

Table of Contents

1.

Introduction

2.

Executive Summary

3.

Coronary Stents:  Background and Overview

4.

Listing of Marketed Coronary Stents: Company Profiles

5.

Listing of Pipeline Coronary Stents: Company Profiles

6.

Coronary Stents: Competitive Assessment of Listed Products

7.

Coronary Stents: Competitive Benchmarking: By Company

8.

Coronary Stents – Commercialisation Activity

9.

Coronary Stents: Regulatory Overview

10.

Coronary Stents: Reimbursement Overview

11.

Coronary Stents: Market Dynamics

12.

PEST Analysis 

13.

Conclusion & Future Growth Perspectives

14.

Appendix

15.

Report Methodology

16.

DelveInsight Capabilities

17.

Disclaimer

18.

About DelveInsight

For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare and Biotech Blog Posts

Related Reports

Biopsy Devices Pipeline Insights

Get comprehensive analysis of Biopsy Devices pipeline devices and key companies including 3DBiopsy Inc, CleveX, Inc., LX Medical Corp, Promaxo Inc, Zamar Care, Vascular BioSciences, Boston Scientific Corp, among others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.  

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/dimapurnewsdesk/deccansamachar.org/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7